Cargando…

HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA

BACKGROUND: Certain risk alleles associated with autoantibody-positive rheumatoid arthritis (RA) have been linked to poorer prognoses. In patients with autoantibody-positive RA, abatacept shows differential efficacy to tumor necrosis factor inhibitors. Our aim was to investigate the relationship bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rigby, William, Buckner, Jane H., Louis Bridges, S., Nys, Marleen, Gao, Sheng, Polinsky, Martin, Ray, Neelanjana, Bykerk, Vivian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449494/ https://www.ncbi.nlm.nih.gov/pubmed/34537057 http://dx.doi.org/10.1186/s13075-021-02607-7

Ejemplares similares

Identification of HLA-DRB1 association to adalimumab immunogenicity
por: Liu, Mohan, et al.
Publicado: (2018)

Influence of HLA-DRB1 P4 binding pocket electric charge on rheumatoid arthritis (RA) susceptibility
por: Michou, L, et al.
Publicado: (2003)

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis
por: Oyama, Munenori, et al.
Publicado: (2020)

Patient‐Reported Outcomes From a Two‐Year Head‐to‐Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis
por: Fleischmann, Roy, et al.
Publicado: (2016)

Effect of abatacept treatment on serum osteoclast-related biomarkers in patients with rheumatoid arthritis (RA): A multicenter RA ultrasound prospective cohort in Japan
por: Kawashiri, Shin-Ya, et al.
Publicado: (2021)

A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis
por: Gourraud, Pierre-Antoine, et al.
Publicado: (2007)

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
por: Weinblatt, Michael E, et al.
Publicado: (2013)

Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
por: Schiff, Michael, et al.
Publicado: (2014)

Impact of the HLA-DRB1 shared epitope on responses to treatment with tofacitinib or abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2021)

Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrative Claims Database
por: Harnett, James, et al.
Publicado: (2016)

Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan
por: Kawashiri, Shin-ya, et al.
Publicado: (2021)

Carriers of HLA-DRB1*04:05 have a better clinical response to abatacept in rheumatoid arthritis
por: Inoue, Mariko, et al.
Publicado: (2023)

PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study
por: Suzuki, Taku, et al.
Publicado: (2013)

Interplay between alcohol, smoking and HLA genes in RA aetiology
por: Hedström, Anna Karin, et al.
Publicado: (2019)

The presentation of the immunodominant epitope of HC gp-39 in the context of the RA-associated HLA class II molecules is specific for RA synovium
por: Baeten, D, et al.
Publicado: (2003)

Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics
por: Regueiro, Cristina, et al.
Publicado: (2019)

A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
por: Harrold, Leslie R., et al.
Publicado: (2017)

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [(223)Ra]RaCl(2) and [(224)Ra]RaCl(2)
por: Lassmann, Michael, et al.
Publicado: (2023)

The RA expeditions
por: Heyerdahl, Thor
Publicado: (1970)

Immunodiagnostic Significance of Anti-RA33 Autoantibodies in Saudi Patients with Rheumatoid Arthritis
por: Al-Mughales, Jamil A.
Publicado: (2015)

Next-Generation Sequencing Reveals That HLA-DRB3, -DRB4, and -DRB5 May Be Associated With Islet Autoantibodies and Risk for Childhood Type 1 Diabetes
por: Zhao, Lue Ping, et al.
Publicado: (2016)

From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis?
por: Molendijk, Marlieke, et al.
Publicado: (2018)

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
por: Sakai, Ryoko, et al.
Publicado: (2015)

Te ngu rá m-ui ra ñaahñu ja ra B-átha de ra B-oot-áhi = El sistema de vida de los otomíes del Valle del Mezquital /
Publicado: (1982)

Submarine groundwater discharge data at meter scale ((223)Ra, (224)Ra, (226)Ra, (228)Ra and (222)Rn) in Indian River Bay (Delaware, US)
por: Duque, Carlos, et al.
Publicado: (2019)

HLA-DRB1 alleles in four Amerindian populations from Argentina and Paraguay
por: Parolín, Maria L., et al.
Publicado: (2009)

Genotyping HLA-DRB1 and HLA-DQB1 alleles in Japanese patients with normal tension glaucoma
por: Suzuki, Misa, et al.
Publicado: (2010)

Classical HLA-DRB1 and DPB1 Alleles Account for HLA Associations with Primary Biliary Cirrhosis
por: Invernizzi, Pietro, et al.
Publicado: (2012)

Detection of the novel HLA allele, HLA‐DRB1*08:112, identified in a Danish family
por: Plesner, Annette, et al.
Publicado: (2022)

Fine Structures in $^{14}C$ Emission of $^{223}Ra$ and $^{224}Ra$
por: Hourani, E, et al.
Publicado: (1991)

Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients
por: Xu, Minjie, et al.
Publicado: (2023)

HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies
por: Pithukpakorn, Manop, et al.
Publicado: (2015)

Ra fisher an appreciation
por: Fienberg, Stephen, et al.
Publicado: (1980)

Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial
por: Baer, Alan N, et al.
Publicado: (2021)

Allele frequency and the associations of HLA-DRB1 and HLA-DQB1 polymorphisms with pemphigus subtypes and disease severity
por: Le, Thanh Thai Van, et al.
Publicado: (2022)

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial
por: Taylor, Peter C., et al.
Publicado: (2019)

Discovery of radioactive decay of $^{222}$Ra and $^{224}$Ra by $^{14}$C emission
por: Price, P B, et al.
Publicado: (1985)

Fine structure in 14C emission from 223Ra and 224Ra
por: Hourani, E, et al.
Publicado: (1991)

On the Feasibility of Rovibrational Laser Cooling of Radioactive RaF$^{+}$ and RaH$^{+}$ Cations
por: Isaev, Timur A, et al.
Publicado: (2021)

Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates
por: Molina, Emily, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1n51um0vogc0lob12mkgtm22ji